174 related articles for article (PubMed ID: 17446287)
1. Enhancement of the in vitro activity of amphotericin B against the biofilms of non-albicans Candida spp. by rifampicin and doxycycline.
El-Azizi M
J Med Microbiol; 2007 May; 56(Pt 5):645-649. PubMed ID: 17446287
[TBL] [Abstract][Full Text] [Related]
2. Effect of amphotericin B alone or in combination with rifampicin or clarithromycin against Candida species biofilms.
Del Pozo JL; Francés ML; Hernáez S; Serrera A; Alonso M; Rubio MF
Int J Artif Organs; 2011 Sep; 34(9):766-70. PubMed ID: 22094555
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species.
Valentín A; Cantón E; Pemán J; Fernandez-Rivero ME; Tormo-Mas MA; Martínez JP
J Antimicrob Chemother; 2016 Dec; 71(12):3449-3452. PubMed ID: 27543657
[TBL] [Abstract][Full Text] [Related]
4. In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms.
Miceli MH; Bernardo SM; Lee SA
Int J Antimicrob Agents; 2009 Oct; 34(4):326-32. PubMed ID: 19515537
[TBL] [Abstract][Full Text] [Related]
5. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex.
Melo AS; Bizerra FC; Freymüller E; Arthington-Skaggs BA; Colombo AL
Med Mycol; 2011 Apr; 49(3):253-62. PubMed ID: 21039308
[TBL] [Abstract][Full Text] [Related]
6. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.
Kuhn DM; George T; Chandra J; Mukherjee PK; Ghannoum MA
Antimicrob Agents Chemother; 2002 Jun; 46(6):1773-80. PubMed ID: 12019089
[TBL] [Abstract][Full Text] [Related]
7. Comparative Study of the Effects of Fluconazole and Voriconazole on Candida glabrata, Candida parapsilosis and Candida rugosa Biofilms.
Madhavan P; Jamal F; Pei CP; Othman F; Karunanidhi A; Ng KP
Mycopathologia; 2018 Jun; 183(3):499-511. PubMed ID: 29380188
[TBL] [Abstract][Full Text] [Related]
8. In vitro method to study antifungal perfusion in Candida biofilms.
Samaranayake YH; Ye J; Yau JY; Cheung BP; Samaranayake LP
J Clin Microbiol; 2005 Feb; 43(2):818-25. PubMed ID: 15695686
[TBL] [Abstract][Full Text] [Related]
9. Patterns of amphotericin B killing kinetics against seven Candida species.
Cantón E; Pemán J; Gobernado M; Viudes A; Espinel-Ingroff A
Antimicrob Agents Chemother; 2004 Jul; 48(7):2477-82. PubMed ID: 15215097
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of liposomal amphotericin B against four species of Candida biofilms in an experimental mouse model of intravascular catheter infection.
Fujimoto K; Takemoto K
J Infect Chemother; 2018 Dec; 24(12):958-964. PubMed ID: 30209024
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of antifungal combinations against Candida albicans biofilms.
Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
[TBL] [Abstract][Full Text] [Related]
12. Relevance of antifungal penetration in biofilm-associated resistance of Candida albicans and non-albicans Candida species.
Singh R; Kumari A; Kaur K; Sethi P; Chakrabarti A
J Med Microbiol; 2018 Jul; 67(7):922-926. PubMed ID: 29767615
[TBL] [Abstract][Full Text] [Related]
13. Biofilms of Candida spp. from the ocular conjunctiva of horses with reduced azole susceptibility: a complicating factor for the treatment of keratomycosis?
Brilhante RSN; Bittencourt PV; de Souza Collares Castelo-Branco D; de Melo Guedes GM; de Oliveira JS; Alencar LP; de Aguiar Cordeiro R; Pinheiro M; Nogueira-Filho EF; de Aquino Pereira-Neto W; Sidrim JJC; Rocha MFG
Vet Ophthalmol; 2017 Nov; 20(6):539-546. PubMed ID: 28417524
[TBL] [Abstract][Full Text] [Related]
14. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
Chiu YS; Chang SC; Hsueh PR; Wang JL; Sun HY; Chen YC
J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981
[TBL] [Abstract][Full Text] [Related]
15. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
16. [In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms].
Valentín A; Cantón E; Pemán J; Quindós G
Rev Iberoam Micol; 2007 Dec; 24(4):272-7. PubMed ID: 18095759
[TBL] [Abstract][Full Text] [Related]
17. In vitro combination therapy with isavuconazole against Candida spp.
Katragkou A; McCarthy M; Meletiadis J; Hussain K; Moradi PW; Strauss GE; Myint KL; Zaw MH; Kovanda LL; Petraitiene R; Roilides E; Walsh TJ; Petraitis V
Med Mycol; 2017 Nov; 55(8):859-868. PubMed ID: 28204571
[TBL] [Abstract][Full Text] [Related]
18. Release of different amphotericin B formulations from PMMA bone cements and their activity against Candida biofilm.
Czuban M; Wulsten D; Wang L; Di Luca M; Trampuz A
Colloids Surf B Biointerfaces; 2019 Nov; 183():110406. PubMed ID: 31401462
[TBL] [Abstract][Full Text] [Related]
19. Dispersal of single and mixed non-albicans Candida species biofilms by β-1,3-glucanase in vitro.
Tan Y; Leonhard M; Ma S; Moser D; Schneider-Stickler B
Microb Pathog; 2017 Dec; 113():342-347. PubMed ID: 29101060
[TBL] [Abstract][Full Text] [Related]
20. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.
Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K
J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
